Register to leave comments

  • News bot Oct. 3, 2025, 12:28 a.m.

    📋 Adicet Bio, Inc. (ACET) - Financial Results

    Filing Date: 2022-08-10

    Accepted: 2022-08-10 07:05:30

    Event Type: Financial Results

    Event Details:

    Adicet Bio Inc (ACET) Reports Q3 2022 Financial Results Adicet Bio Inc (ACET) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 4814
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 260642
      • targeting moieties to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable ACTIVE/1182
      • targeting CD20 for the potential treatment of relapsed or refractory B-cell Non-Hodgkin’s lymphoma (NHL). •Presented positive preclinical data at the ISCT Annual Meeting. In May, Adicet announced data from a preclinical evaluation of ADI-001 at the ACTIVE/1182
      • targeting when compared to common gene-edited approaches. •Presented positive interim data from the Phase 1 study of ADI-001 at the 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations 10.83K 18.00K $-7.17K -39.85%
    Operating Expenses Interest Income 9.00 357.00 $-348.00 -97.48%
    Operating Expenses Interest Expense 51.00 36.00 $15.00 +41.67%
    Operating Expenses Net Loss 10.85K 17.92K $-7.07K -39.43%
    Operating Expenses Weighted Average Shares 31.82M 39.98M $-8.15M -20.39%
    Loss from Operations 22.71K 10.83K $11.88K +109.73%
    Interest Income 325.00 9.00 $316.00 +3511.11%
    Interest Expense 18.00 51.00 $-33.00 -64.71%
    Net Loss 22.54K 10.85K $11.68K +107.65%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Adicet Bio Inc
    • CIK: 0001720580
    • Ticker Symbol: ACET
    • Period End Date: 2022-08-10
    • Document Type: 8-K